• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

When will Japan remove OB?

Anonymous

Guest
It is not understandable why OB is still here. Failure after failure with a demoralized sales force that is dying for a new leadership. Please Japan, OB is the cancer here. He needs to go. Please help us. OB has been here for too long and his presence prevents others from making bold decisions that are needed to save this company.
 

<